Filing Details

Accession Number:
0001209191-21-004102
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-19 18:29:14
Reporting Period:
2021-01-15
Accepted Time:
2021-01-19 18:29:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614568 Jane Wright-Mitchell C/O Vaxcyte, Inc.
353 Hatch Drive
Foster City CA 94404
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-15 2,500 $2.03 4,062 No 4 M Direct
Common Stock Disposition 2021-01-15 2,500 $26.00 1,562 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-01-15 2,500 $0.00 2,500 $2.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
204,968 2029-03-20 No 4 M Direct
Footnotes
  1. Includes 1,562 shares acquired under the Employee Stock Purchase Plan on November 17, 2020.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.